These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23521004)

  • 1. Design, synthesis, and bioactivity of pyrazole acid derivatives as endothelin receptor antagonists.
    Cai J; Liu L; Chen J; Cao M; Ji M
    Med Chem; 2013 Dec; 9(8):1113-22. PubMed ID: 23521004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid peptides constructed from RES-701-1, an endothelin B receptor antagonist, and endothelin; binding selectivity for endothelin receptors and their pharmacological activity.
    Shibata K; Suzawa T; Ohno T; Yamada K; Tanaka T; Tsukuda E; Matsuda Y; Yamasaki M
    Bioorg Med Chem; 1998 Dec; 6(12):2459-67. PubMed ID: 9925302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptide sulfonamides as endothelin ETA/ETB receptor antagonists.
    Ksander GM; Shetty SS; DelGrande D; Balwierczak JL; Bruseo CW; Savage P; deJesus R; Yuan A; Webb RL; Jeng AY
    Can J Physiol Pharmacol; 2002 May; 80(5):464-9. PubMed ID: 12056554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and evaluation of 1,3,6-trisubstituted-4-oxo-1,4-dihydroquinoline-2-carboxylic acid derivatives as ET
    Khadtare N; Stephani R; Korlipara V
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2281-2285. PubMed ID: 28462837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of 3-(1H-indol-3-yl)pyrazole-5-carboxylic acid derivatives.
    Zhang D; Wang G; Tan C; Xu W; Pei Y; Huo L
    Arch Pharm Res; 2011 Mar; 34(3):343-55. PubMed ID: 21547665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of phenoxybutanoic acid derivatives as potent endothelin antagonists with antihypertensive activity.
    Cai J; Liu L; Hong KH; Wang P; Li L; Cao M; Sun C; Wu X; Zong X; Chen J; Ji M
    Bioorg Med Chem; 2015 Feb; 23(4):657-67. PubMed ID: 25614116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF.
    Warner TD; Allcock GH; Corder R; Vane JR
    Br J Pharmacol; 1993 Oct; 110(2):777-82. PubMed ID: 8242251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrrolidine-3-carboxylic acids as endothelin antagonists. 3. Discovery of a potent, 2-nonaryl, highly selective ETA antagonist (A-216546).
    Liu G; Henry KJ; Szczepankiewicz BG; Winn M; Kozmina NS; Boyd SA; Wasicak J; von Geldern TW; Wu-Wong JR; Chiou WJ; Dixon DB; Nguyen B; Marsh KC; Opgenorth TJ
    J Med Chem; 1998 Aug; 41(17):3261-75. PubMed ID: 9703472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent nonpeptide endothelin antagonists: synthesis and structure-activity relationships of pyrazole-5-carboxylic acids.
    Zhang J; Didierlaurent S; Fortin M; Lefrançois D; Uridat E; Vevert JP
    Bioorg Med Chem Lett; 2000 Nov; 10(22):2575-8. PubMed ID: 11086733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationships of potent and orally active sulfonamide ETB selective antagonists.
    Kanda Y; Kawanishi Y; Oda K; Sakata T; Mihara SI; Asakura K; Kanemasa T; Ninomiya M; Fujimoto M; Konoike T
    Bioorg Med Chem; 2001 Apr; 9(4):897-907. PubMed ID: 11354672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus.
    Hay DW; Luttmann MA; Beck G; Ohlstein EH
    Br J Pharmacol; 1996 Jul; 118(5):1209-17. PubMed ID: 8818345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic characterization of the novel, orally available endothelin-A--selective antagonist SB 247083.
    Douglas SA; Nambi P; Gellai M; Luengo JI; Xiang JN; Brooks DP; Ruffolo RR; Elliott JD; Ohlstein EH
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S273-6. PubMed ID: 9595458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of endothelin receptors in rat renal artery in vitro.
    Clark KL; Pierre L
    Br J Pharmacol; 1995 Feb; 114(4):785-90. PubMed ID: 7773538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and acrosin inhibitory activities of substituted ethyl 5-(4-aminophenyl)-1H-pyrazole-3-carboxylate derivatives.
    Qi J; Zhu J; Liu X; Ding L; Zheng C; Han G; Lv J; Zhou Y
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5822-5. PubMed ID: 21880490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin receptor antagonist activity of (R)-(-)-2-(benzo[1,3]dioxol-5-yl)-N-(4-isopropylphenylsulfonyl)-2-(6-methyl- 2-propylpyridin-3-yloxy)acetamide hydrochloride (PABSA) in rat aortic smooth muscle cells and isolated rat thoracic aorta.
    Iwasaki T; Hayasaki-Kajiwara Y; Matsuo Y; Nakajima M
    Arzneimittelforschung; 2001; 51(7):529-34. PubMed ID: 11505783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and bioevaluation of 1-phenyl-pyrazole-4-carboxylic acid derivatives as potent xanthine oxidoreductase inhibitors.
    Li J; Wu F; Liu X; Zou Y; Chen H; Li Z; Zhang L
    Eur J Med Chem; 2017 Nov; 140():20-30. PubMed ID: 28918097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonpeptide endothelin receptor antagonists. VI: Pharmacological characterization of SB 217242, a potent and highly bioavailable endothelin receptor antagonist.
    Ohlstein EH; Nambi P; Lago A; Hay DW; Beck G; Fong KL; Eddy EP; Smith P; Ellens H; Elliott JD
    J Pharmacol Exp Ther; 1996 Feb; 276(2):609-15. PubMed ID: 8632328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart.
    Peter MG; Davenport AP
    Br J Pharmacol; 1996 Feb; 117(3):455-462. PubMed ID: 8821534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma- and cerebrospinal fluid-immunoreactive endothelin-1: effects of nonpeptide endothelin receptor antagonists with diverse affinity profiles for endothelin-A and endothelin-B receptors.
    Willette RN; Sauermelch CF; Storer BL; Guiney S; Luengo JI; Xiang JN; Elliott JD; Ohlstein EH
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S149-57. PubMed ID: 9595425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
    Warner TD; Allcock GH; Vane JR
    Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.